238 related articles for article (PubMed ID: 25860569)
1. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa.
Kim YE; Remme JH; Steinmann P; Stolk WA; Roungou JB; Tediosi F
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003664. PubMed ID: 25860569
[TBL] [Abstract][Full Text] [Related]
2. Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.
Kim YE; Sicuri E; Tediosi F
PLoS Negl Trop Dis; 2015; 9(9):e0004056. PubMed ID: 26360917
[TBL] [Abstract][Full Text] [Related]
3. Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal.
Walker M; Stolk WA; Dixon MA; Bottomley C; Diawara L; Traoré MO; de Vlas SJ; Basáñez MG
Epidemics; 2017 Mar; 18():4-15. PubMed ID: 28279455
[TBL] [Abstract][Full Text] [Related]
4. River blindness: a success story under threat?
Basáñez MG; Pion SD; Churcher TS; Breitling LP; Little MP; Boussinesq M
PLoS Med; 2006 Sep; 3(9):e371. PubMed ID: 17002504
[TBL] [Abstract][Full Text] [Related]
5. Progress toward elimination of onchocerciasis in the Americas - 1993-2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 May; 62(20):405-8. PubMed ID: 23698606
[TBL] [Abstract][Full Text] [Related]
6. From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
Colebunders R; Siewe Fodjo JN; Hopkins A; Hotterbeekx A; Lakwo TL; Kalinga A; Logora MY; Basáñez MG
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007407. PubMed ID: 31318857
[No Abstract] [Full Text] [Related]
7. Does Increasing Treatment Frequency Address Suboptimal Responses to Ivermectin for the Control and Elimination of River Blindness?
Frempong KK; Walker M; Cheke RA; Tetevi EJ; Gyan ET; Owusu EO; Wilson MD; Boakye DA; Taylor MJ; Biritwum NK; Osei-Atweneboana M; Basáñez MG
Clin Infect Dis; 2016 Jun; 62(11):1338-1347. PubMed ID: 27001801
[TBL] [Abstract][Full Text] [Related]
8. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.
Turner HC; Walker M; Churcher TS; Basáñez MG
Parasit Vectors; 2014 May; 7():241. PubMed ID: 24886747
[TBL] [Abstract][Full Text] [Related]
9. River Blindness: Mathematical Models for Control and Elimination.
Basáñez MG; Walker M; Turner HC; Coffeng LE; de Vlas SJ; Stolk WA
Adv Parasitol; 2016; 94():247-341. PubMed ID: 27756456
[TBL] [Abstract][Full Text] [Related]
10. Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and Uganda.
Meredith SE; Cross C; Amazigo UV
Health Res Policy Syst; 2012 May; 10():16. PubMed ID: 22574885
[TBL] [Abstract][Full Text] [Related]
11. River blindness eliminated in Colombia.
West S; Munoz B; Sommer A
Ophthalmic Epidemiol; 2013 Oct; 20(5):258-9. PubMed ID: 23968291
[No Abstract] [Full Text] [Related]
12. The Carter Center's assistance to river blindness control programs: establishing treatment objectives and goals for monitoring ivermectin delivery systems on two continents.
Richards FO; Miri ES; Katabarwa M; Eyamba A; Sauerbrey M; Zea-Flores G; Korve K; Mathai W; Homeida MA; Mueller I; Hilyer E; Hopkins DR
Am J Trop Med Hyg; 2001 Aug; 65(2):108-14. PubMed ID: 11508383
[TBL] [Abstract][Full Text] [Related]
13. The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
Vinkeles Melchers NVS; Stolk WA; van Loon W; Pedrique B; Bakker R; Murdoch ME; de Vlas SJ; Coffeng LE
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009604. PubMed ID: 34310602
[TBL] [Abstract][Full Text] [Related]
14. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Cupp EW; Sauerbrey M; Richards F
Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
[TBL] [Abstract][Full Text] [Related]
15. River blindness elimination in Columbia.
Burki T
Lancet Infect Dis; 2013 Nov; 13(11):922-3. PubMed ID: 24319775
[No Abstract] [Full Text] [Related]
16. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
[TBL] [Abstract][Full Text] [Related]
17. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.
Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
Infect Dis Poverty; 2019 Jul; 8(1):60. PubMed ID: 31269966
[TBL] [Abstract][Full Text] [Related]
18. Onchocerciasis.
Taylor HR
Int Ophthalmol; 1990 May; 14(3):189-94. PubMed ID: 2188920
[TBL] [Abstract][Full Text] [Related]
19. The future of onchocerciasis control in Africa.
Hodgkin C; Molyneux DH; Abiose A; Philippon B; Reich MR; Remme JH; Thylefors B; Traore M; Grepin K
PLoS Negl Trop Dis; 2007 Oct; 1(1):e74. PubMed ID: 17989787
[No Abstract] [Full Text] [Related]
20. After 70 years of fighting an age-old scourge, onchocerciasis in Uganda, the end is in sight.
Katabarwa MN; Lakwo T; Habomugisha P; Unnasch TR; Garms R; Hudson-Davis L; Byamukama E; Khainza A; Ngorok J; Tukahebwa E; Richards FO
Int Health; 2018 Mar; 10(suppl_1):i79-i88. PubMed ID: 29471335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
